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Abstract
Objectives—Irritable bowel syndrome (IBS) patients show pain hypersensitivity and
hypercontractility in response to colonic or rectal distention. Aims were to determine whether
predominant bowel habits and IBS symptom severity are related to pain sensitivity, colon motility,
or smooth muscle tone.
Methods—129 patients classified as IBS with diarrhea (IBS-D, n=44), IBS with constipation
(IBS-C, n=29), mixed IBS (IBS-M, n=45) and unspecified IBS (IBS-U, n=11) based on stool
consistency, and 30 healthy controls (HC) were studied. A manometric catheter containing a 600-
ml capacity plastic bag was positioned in the descending colon. Pain threshold was assessed using
a barostat. Motility was assessed for 10 min with the bag minimally inflated (individual operating
pressure or IOP), 10 min at 20 mmHg above the IOP, and for 15-min recovery following bag
inflation. Motility was also recorded for 30 min following an 810-kcal meal.
Results—Compared to HC, IBS patients had lower pain thresholds (medians: 30 vs. 40 mmHg,
p<0.01), but IBS subtypes were not different. IBS symptom severity was correlated with pain
thresholds (rho=-0.36, p<0.001). During distention, the motility index (MI) was significantly
higher in IBS compared to HC (909±73 vs. 563±78, p<0.01). Average barostat bag volume at
baseline was higher (muscle tone lower) in HC compared to IBS-D and IBS-M but not compared
to IBS-C. The baseline MI and bag volume differed between IBS-D and IBS-C and correlated
with symptoms of abdominal distention and dissatisfaction with bowel movements. Pain
thresholds and MI during distention were uncorrelated.
Conclusions—Pain sensitivity and colon motility are independent factors contributing to IBS
symptoms. Treatment may need to address both and to be specific to predominant bowel habit.
Address for correspondence: Motoyori Kanazawa, MD, PhD Department of Behavioral Medicine, Tohoku University Graduate
School of Medicine, 2-1 Seiryo, Aoba, Sendai 980-8575, Japan. Phone & Fax: +81-22-717-7655 mkanazw@mail.tains.tohoku.ac.jp.
Conflicts of Interest and Author Roles: William E. Whitehead, Ph.D., is the guarantor of this paper, and he participated in study
design, data collection, data analysis, and manuscript preparation. Motoyori Kanazawa, M.D., Ph.D., participated in study design, data
analysis, and preparation of the manuscript. Olafur S. Palsson, Psy.D., participated in study design and data analysis. Syed IM Thiwan,
M.D., participated in data collection. Marsha J. Turner, M.A., participated in data collection. Miranda AL van Tilburg, Ph.D.,
participated in data collection and data analysis. Lisa M. Gangarosa, M.D., participated in data collection. Denesh K. Chitkara, M.D.,
participated in data collection. Shin Fukudo, M.D., Ph.D., participated in data analysis and manuscript preparation. Douglas A.




Am J Gastroenterol. Author manuscript; available in PMC 2013 December 07.
Published in final edited form as:














irritable bowel syndrome; visceral hypersensitivity; colonic motility; symptom severity; subtypes
of bowel habit
Introduction
There is no consensus on the pathophysiology of IBS. In several studies, IBS patients had
lower perception thresholds and increased sensations of discomfort to intraluminal
distention in the sigmoid colon1-3 and the rectum4-6 (visceral hypersensitivity) or more
exaggerated GI motility responses to experimental stress7, 8, phasic intraluminal
distention9, 10 or eating11, 12 (hyper-reactive motility) compared to healthy controls (HC).
However, there is only limited data on the extent to which visceral hypersensitivity and
hyper-reactive motility correlate with each other and influence clinical symptoms of
abdominal pain and altered bowel habits13.
Some reports suggest that patients with diarrhea-dominant IBS (IBS-D) have increased
visceral sensitivity compared with those with constipation-dominant IBS (IBS-C)14, 15, but
others failed to find differences between subtypes16, 17. Previous reports may be inconsistent
due to a small number of subjects or other methodological differences. The guidelines for
sub-classifying IBS into IBS-C and IBS-D were recently revised18. The former Rome II
criteria19 used multiple signs and symptoms to make this sub-classification, which were
complex and possibly unreliable, but the Rome III criteria simplified this classification by
using only stool consistency18. Most patients with IBS have a stool frequency within the
normal range regardless of bowel pattern20, but stool consistency (from watery to hard)
reflects intestinal transit time21. In this study, we used the Rome III criteria to identify
subtypes of IBS.
Aims of the present study were to (1) compare IBS patients to healthy controls (HC) with
respect to pain sensitivity and tonic and phasic colon motility, (2) determine whether IBS
subtypes defined by usual stool consistency differ on these variables, (3) determine whether
pain sensitivity is related to (i.e., correlated with) phasic and tonic motility, and (4)




This was a prospective study. Subjects were recruited by advertisements or physician
referrals and screened by telephone. The study population consisted of 136 patients who
fulfilled Rome II criteria for IBS, received a physician diagnosis of IBS, and had current
symptoms (abdominal pain or discomfort at least one-fourth of the time in the last 3
months). These subjects had no history of gastrointestinal surgery (other than appendectomy
or cholecystectomy), inflammatory bowel disease, celiac disease, lactose malabsorption,
heart disease or diabetes mellitus, and they were not pregnant at the time of study.
Patients with IBS were classified by usual stool consistency into subtypes according to
Rome III guidelines18: IBS-D was defined as loose (mushy) or watery stool ≥25% and hard
or lumpy stool <25% of bowel movements, and IBS-C was defined as hard or lumpy stool
≥25% and loose or watery stool <25% of bowel movements. IBS with mixed bowel habits
(IBS-M) was defined as loose or watery stools ≥25% of the time plus hard or lumpy stools
≥25% of the time, and IBS with normal bowel habits (IBS-U, for unclassifiable) was defined
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by neither loose/watery nor hard/lumpy stools 25% or more of the time. The Rome III
descriptions of stool consistencies were adapted from the Bristol Stool Scale, but the
pictures of different stool forms were not provided to subjects.
The control population was recruited by advertisement and consisted of 33 subjects without
any significant or recurring gastrointestinal symptoms. Exclusion criteria were average stool
frequency of less than 3/week or more than 3/day, abdominal pain or use of a laxative or
anti-diarrheal agent on more than two occasions over the prior year, history of alcohol or
substance abuse, a psychiatric diagnosis, or any of the medical conditions listed above for
the IBS patients. The study was approved by the Institutional Review Board of the
University of North Carolina (UNC), and all subjects provided written informed consent.
Study design
Subjects were admitted to the General Clinical Research Center at the University of North
Carolina for a 24-30 hour period. They were asked to fast for at least 4 hours prior to
reporting for admission. On the day of admission, a medical history, physical examination,
and breath test for lactose intolerance and small intestinal bacterial overgrowth were
completed. The Irritable Bowel Syndrome Severity Scale22 (IBS-SS), the Brief Symptom
Inventory-1823 (BSI-18), and other questionnaires were completed on a computer terminal
during the breath test. A low fiber meal was consumed at approximately 5:00 pm. Day 1
ended with a bowel cleanout consisting of 1.5 oz of Fleet's phosphosoda consumed at 6:00
pm and repeated at 9:00 pm.
Questionnaires—The IBS-SS22 is a validated scale for measuring the overall severity of
IBS symptoms. It consists of 5 equally weighted questions. Subjects are asked to indicate for
the past 10 days the average intensity of abdominal pain, the number of days with any
abdominal pain, the average severity of abdominal distention, dissatisfaction with bowel
habits, and the degree to which bowel symptoms interfered with their usual activities.
Response to all except the pain frequency question are on a 1-100 numeric scale (“none” to
“worst ever”), and the number of days of pain in the past 10 days is multiplied by 10 to
arrive at a 0-100 score for this item. The 5 questions are added to arrive at a total score of
0-500.
The BSI-1823 is a validated questionnaire for measuring the degree of psychological distress
over the past week. Subjects are asked how much they were bothered by each of 18
symptoms, and they respond on a 5-point ordinal scale from “not at all bothered” to
“extremely.” There are 3 subscales – anxiety, depression, and somatization – as well as a
global severity index (GSI). Sum scores for each subscale and the GSI are converted to
standardized scores where the mean for the healthy population is a score of 50 and each
standard deviation from the mean is equal to 10 scale points; thus, a score of 60 is one
standard deviation above the mean. These standardized scores adjust for sex differences in
the reporting of psychological symptoms, so BSI-18 scores for males and females can be
pooled together.
Equipment—The barostat is a computer-controlled pump (Distender II model, G&J
Electronics, Willodale, Ontario, Canada) used for testing sensory thresholds and smooth
muscle tone in the lumen of the bowel. It inflates a plastic bag to a predefined pressure and
holds this pressure constant for a fixed period of time by adding or subtracting air. Volumes
and pressures are recorded 16 times per second and are displayed graphically in real time.
The rate of inflation and deflation was 38 ml/sec. Controlling the pump by means of a
computer program made it possible to present complex sequences of distentions.
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The motility catheter (Model C7-CB-0026, Mui Scientific, Mississauga, Ontario, Canada) is
5 mm in outside diameter. It consists of a bundle of smaller polyethylene tubes bonded
together and includes a central lumen which accommodates a guide wire, 2 lumens which
open inside the bag (one to inflate/deflate the bag and a second to monitor pressure inside
the bag), plus 4 small catheters used to measure pressures 2.5 and 5 cm from the proximal
and distal edges of the bag. A disposable, 10 cm long, 600 ml capacity polyethylene bag
(Model CT-BP600R, Mui Scientific) was attached to the surface of the motility catheter and
tied with surgical thread.
The pneumohydraulic pump (8 channel hydraulic capillary infusion system, Arndorfer Inc,
Greendale, Wisconsin) uses a tank of compressed air to force de-gassed sterile water from a
reservoir through 4 capillary (very small diameter) catheters which are connected to 4
pressure transducers. These pressure transducers are also connected to the 4 small catheters
in the motility catheter which open above and below the barostat bag. Water is perfused
through the pressure transducers and the perfusion catheters at a rate of 0.37 ml/min.
Because there is a continuous column of water connecting the pressure transducer to the
openings on the outside of the motility catheter, pressure changes occurring at the openings
are transmitted up the column of water to the pressure transducers. The outputs of these
pressure transducers were continuously recorded (see below).
The physiological recorder used to record phasic and tonic motility changes above and
below the balloon was a Synectics Polygram (Medtronic Inc., Minneapolis, MN). This
instrument continuously recorded pressure changes above and below the bag and stored
them in a digital file. A research nurse marked these recordings to indicate which
experimental condition was in effect.
Colonic sensory and motility testing
All physiological and sensory testing was performed on Day 2 according to the protocol in
Figure 1. On the morning of Day 2 at approximately 8:00 AM, the barostat catheter was
placed in the descending colon for sensory and motility testing. First, a guide wire was
inserted to the level of the splenic flexure using a flexible sigmoidoscope. The
sigmoidoscope was then withdrawn and the motility catheter was guided over this wire. The
guide wire was then withdrawn and barostat placement was confirmed by fluoroscopy.
Following catheter placement, the subject rested for 90 min before testing began. No
sedation was used during sigmoidoscopy. Subjects were not permitted to have food until the
test meal (see Figure 1).
Sample distention and determination of individual operating pressure—
Subjects were instructed to give separate ratings of the intensity of pain and urgency to
defecate experienced at the end of each distention, using a six point scale (0= no sensation; 1
= weak; 2= mild; 3 = moderate; 4 = strong; 5 = intense). The scale was visible to subjects
during the procedure. Sample distentions were then performed during which the barostat bag
was inflated in a stepwise fashion by increasing bag pressure by 4 mmHg every 15 seconds
until the subject reported moderate pain (rating of 3). The sample distentions served three
purposes: (1) to insure that the barostat bag was unfolded; (2) to teach the subject how to use
the rating scale to describe the intensity of colonic sensations; and (3) to decrease
anticipatory anxiety. The barostat bag was then slowly inflated with 30 ml of air and the
pressure was allowed to equilibrate for 3 minutes. The average bag pressure during the last
15 seconds defined the individual operating pressure (IOP)24, which is the minimum
pressure required to overcome mechanical forces and inflate the bag with 30 ml of air. All
sensory and motility testing was done with the subject lying in a left-lateral position to
minimize pressures due to the weight of overlying body tissues compressing the bowel.
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Ascending method of limits (AML)—Pain thresholds in the colon were assessed using
the ascending method of limits24. Phasic distentions were 30 seconds in duration and were
separated by 30 second rest intervals. Distentions starting at the IOP and progressively
increased in 2 mmHg steps until either the subject requested the research nurse to stop the
protocol or 48 mmHg was reached. The pain threshold was defined as the amount of
pressure above IOP at which the subject first reported moderate pain (absolute distending
pressure minus the IOP). If the subject reached 48 mmHg without reporting moderate pain,
then the pain threshold was defined as 50 mmHg minus the IOP. After measuring pain
thresholds, there was a 15 min rest period. Individual pain thresholds are shown in Figure 2.
Colonic phasic motility—Phasic contractions were measured from the perfusion ports
above and below the bag under the following conditions: (a) during the fasting baseline for
10 min at the IOP, (b) during distention for 10 min at a pressure of IOP+20 mmHg, (c)
during a recovery period after intraluminal distention for 15 min at the IOP, and (d)
following the meal for 30 min at the IOP. These tracings were visually screened to exclude
artifact, defined as wave amplitudes less than 5 mmHg or with durations less than 6 sec. The
beginning and ending inflection points for each individual contraction were identified
visually and the area under the curve was calculated using computer software (Polygram,
Lower GI Edition, Version 5.06; Synectics Medical, now Medtronic, Inc., Minneapolis,
MN). These areas were added together, then divided by recording time in seconds
(excluding the time occupied by movement artifact), and multiplied by 100. The motility
index (MI) was the average of phasic contractions at 4 perfusion ports.
Colonic tonic motility—Average barostat bag volume in each period was recorded as a
measure of smooth muscle tone24. Muscle tone was measured during the fasting baseline,
recovery period after intraluminal distention, and following the meal. The average volume
required to maintain the barostat bag at a constant pressure was recorded. The average
barostat bag volumes in successive 5 min blocks constitutes an index of smooth muscle tone.
Postprandial motility—The test meal was standardized and contained 810 kcals and 38
grams of fat. Subjects were asked to consume the meal within 10 minutes. Immediately after
completing the meal, the patient returned to the prone position and bag pressure was
maintained at the IOP for 30 min (the post-prandial period). Phasic and tonic motility were
recorded throughout this period.
Data analysis
Phasic and tonic motility were assessed at baseline and in response to stimulation with
intraluminal distention and meal ingestion. Because there were differences between groups
at baseline, the response to stimulation had to be assessed after adjusting for baseline
differences. To accomplish this, we expressed stimulated values as a percent of baseline
values. Absolute values are also presented in Table 2 to allow the reader to compare these
two methods of data presentation. Statistical comparisons were performed on both the
percent-of-baseline values and the absolute values.
Comparisons between groups were made using the Kruskal-Wallis test, followed by Mann-
Whitney U test. Correlations between variables were limited to the IBS patients, and
employed the Spearman non-parametric correlation coefficient to account for non-normal
distributions of some variables. Multiple linear regression was used to determine which
variables were most strongly associated with IBS symptom severity. In this analysis, dummy
regression terms to code for usual stool consistency (hard or lumpy stool ≥25% and loose or
watery stool ≥25%) were used (1=yes, 0=no). For all analyses, a p-value of 0.05 without
adjustment for multiple comparisons, defined statistical significance.
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Although this is the largest study to be reported comparing subgroups of IBS patients on
physiological parameters, the subgroups were unequal in size (n=45 for IBS-D, n=29 for
IBS-C. n=45 for IBS-M, and n=11 for IBS-U), and consequently the statistical power of
between-group comparisons and correlations varied and could lead to spurious conclusions.
Three steps were taken to avoid this: (1) No statistical comparisons were made to the IBS-U
group and no correlations were reported for this subgroup because it was too small. (2) For
other between-group comparisons, we identified the minimum Z-score for a Mann-Whitney
U test involving the smallest group (IBS-C) that was significant at p<0.05 and interpreted
other comparisons as statistically significant only if they exceeded this critical value. (3)
Similarly for Spearman nonparametric correlations, we identified the smallest correlation of
a group of size n=29 that was significant at p<0.05 and interpreted other correlations as
statistically significant only if they exceeded this critical value.
Results
Eligible subjects
129 IBS patients (20 males; mean age 35.8 years) and 30 healthy control subjects (8 males;
37.2 years) underwent both colonic sensory and motility tests. Seven additional IBS patients
were enrolled but did not undergo colonic sensory and motility testing: three refused flexible
sigmoidscopy, two began but could not tolerate completion of unsedated sigmoidscopy, one
had an extremely elevated blood pressure, and one had colonic inflammation detected on
sigmoidscopy. Three additional control subjects were similarly screened but excluded: one
did not tolerate the flexible sigmoidscopy and two had exclusionary medical conditions that
were detected during the study (lactose intolerance in one and prior colonic surgery in the
other).
Two of 129 eligible patients did not complete the postprandial assessment due to unpleasant
symptoms experienced during the test meal. One patient did not complete only the
postprandial tonic motility assessment due to equipment failure. Two patients and one
control subject did not report symptom severity on the IBS-SS. No serious adverse events
were observed.
Table 1 shows demographic characteristics of the sample. There were no differences
between HC and IBS patients in gender, age, or race/ethnicity.
IBS Symptom severity and psychological distress
Scores on the IBS-SS and the BSI-18 are shown in Table 1. IBS patients scored significantly
higher than HC on the IBS-SS total score and all subscales of the IBS-SS. Figure A1 in the
appendix shows IBS-SS scores for all subjects separated into groups. This figure
demonstrates that the IBS-SS scores were normally distributed within the IBS subgroups
and that there was no tendency for the subtypes of IBS to differ from each other. On the
BSI-18, IBS patients also scored significantly higher than HC on all subscales and on the
global symptom index. However, there were no significant differences among the IBS
subtypes.
Pain sensitivity
IBS patients had significantly lower thresholds for pain on the barostat test compared to HC
(Table 2). Figure 2 shows the distribution of pain thresholds for each group. All IBS
subtypes had significantly lower pain thresholds than HC, and for 57% of IBS patients, pain
thresholds were below the 95 percent confidence interval for controls (34 mmHg). There
were no significant differences in pain thresholds between the subtypes of IBS.
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Baseline—When tested under baseline conditions (fasting, no intraluminal distention), the
MI (phasic contractions) was no different in the total IBS patient group vs. HC (Table 2).
However, the IBS-D group showed significantly more phasic contractions than IBS-C.
Response to intraluminal distention—As shown in Table 2, both HC and IBS groups
showed a significant increase in MI during intraluminal distention. The magnitude of this
increase was greater in the IBS patients compared to HC. The magnitude of the increase in
MI from baseline to distention was significantly greater in the IBS-C and IBS-M groups
compared to HC (p<0.05), but the subtypes of IBS did not differ from each other in
magnitude of increase in phasic motility from baseline. Figure A2 in the appendix shows
responses to distention as a percent of baseline values. Statistical analysis of these baseline-
adjusted values showed the same significant comparisons as did analysis of the absolute
values.
During the recovery period following intraluminal distention, the MI decreased and was not
significantly different from baseline for either HC or IBS patients (all subtypes combined).
When the IBS subtypes were compared to each other during recovery from distention, there
were no significant differences between the subtypes.
Response to eating—As shown in Table 2, both HC and IBS showed significant
increases in MI following the meal, but the magnitude of this increase was similar in IBS vs.
HC. There was no significant difference between IBS subtypes in the magnitude of the
meal-stimulated increase in phasic contractions. Figure A2 in the appendix shows responses
to the meal as a percent of baseline values. Statistical analysis of these baseline-adjusted
values also failed to show differences between HC vs. IBS or between IBS subgroups.
Smooth muscle tone measured by barostat bag volume
Baseline: When tested in the fasting state and without intraluminal distention, barostat bag
volumes were smaller (i.e., smooth muscle tone was greater) in IBS compared to HC (Table
2). Comparison of IBS subtypes showed that the IBS-D subgroup had significantly lower
bag volumes than the IBS-C group. Since IBS-M patients, like IBS-D patients, have loose or
watery stools at least 25% of the time, we performed a post-hoc comparison of the IBS-D
and IBS-M groups combined vs. the IBS-C and IBS-U groups combined and found that this
was significant; as a group, patients who reported ≥25% of bowel movements as loose or
watery had lower barostat bag volumes (35.4±2.7 mL) than IBS patients whose bowel
movements were rarely loose or watery (50.5±6.3 mL, p<0.05).
Recovery period following distention—Muscle tone could not be measured during
distention because barostat bag volumes during distention reflect compliance rather than
tone. Barostat bag volumes during recovery from distention were approximately the same as
during baseline and again showed lower bag volumes in the total IBS sample and in the IBS-
D and IBS-M subgroups compared to the HC group (Table 2).
Response to eating—As shown in Table 2, both HC and IBS exhibited a statistically
significant and profound decrease in bag volumes (i.e., an increase in smooth muscle tone)
following the meal. The magnitude of this change in bag volume was not significantly
different between IBS and HC. When the IBS subtypes were compared to each other, there
was no difference in muscle tone between the subtypes (Table 2). Figure A3 in the appendix
shows meal-related changes in bag volume as a percent of baseline values. Statistical
analysis of these baseline-adjusted values also failed to show differences between IBS and
HC or differences between IBS subtypes.
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Relationship between motility and sensory thresholds
Figure 3 shows the relationship between the MI and the threshold for pain perception.
Dotted vertical and horizontal lines show where the 95 percent confidence interval for HC
lies on each of these dimensions. The overall correlation between motility during distention
and pain sensory threshold in IBS patients was rho=-0.06 (p>0.1, see Figure 3), suggesting
that these are independent dimensions.
Relationship of IBS symptom severity to visceral perception, colonic motility, and
psychological symptoms
When all subtypes of IBS were pooled together, the pain threshold was significantly
correlated with overall symptom severity (rho=-0.36, p<0.001), intensity of abdominal pain
(rho=-0.34, p<0.001), frequency of abdominal pain (rho=-0.32, p<0.001), and severity of
abdominal distention (rho=-0.31, p<0.001). Neither phasic motility nor smooth muscle tone
was significantly correlated with overall symptom severity or with individual symptoms on
the IBS-SS. However, because there were differences in motility between IBS-D and IBS-C
(as shown in Table 2), it was possible that associations between motility and clinical
symptoms were obscured by pooling all IBS subtypes together. Therefore, the correlations
between motility parameters and key clinical symptoms (frequency of clinical pain, intensity
of abdominal distention, and dissatisfaction with bowel habits) were computed for each IBS
subtype separately. These data are summarized below.
Abdominal pain—Clinical pain frequency was significantly correlated with pain threshold
in IBS-D (rho=-0.33, p<0.05) and this correlation was even stronger in IBS-M (rho=-0.50,
p<0.001). However, there was no correlation between pain threshold and clinical pain
frequency in IBS-C (rho=-0.13, NS).
Abdominal distention—The motility index was negatively correlated with severity of
abdominal distention in IBS-C (rho=-0.39, p<0.05), but the motility index was unrelated to
distention severity in IBS-D and IBS-M. The negative correlation indicates that as the
amount of phasic contractions increased in IBS-C, the severity of distention decreased.
Dissatisfaction with bowel habits—The symptom of dissatisfaction with bowel habits
correlated negatively (rho=-0.40, p<0.01) with postprandial smooth muscle tone in IBS-D
(i.e., smaller bag volumes due to greater smooth muscle tone were associated with greater
dissatisfaction with bowel habits). Among IBS-M and IBS-C, there was no association with
muscle tone.
Psychological symptoms—When all IBS patients were analyzed together as one group,
somatization (the tendency to notice and report somatic sensations possibly indicative of
disease) was significantly correlated with overall IBS symptom severity (rho=0.30, p<0.01),
and with the IBS-SS subscales for pain frequency (rho=0.23, p<0.05) and abdominal
distention (rho=0.21, p<0.05). Anxiety and depression were not significantly related to
bowel symptoms. When the subtypes of IBS were analyzed separately, the association
between somatization and bowel symptom severity was found to be significant only for the
IBS-M subtype: (rho=0.36 for pain frequency, rho=0.30 for abdominal distention, and
rho=-0.30 for dissatisfaction with bowel movements; all significant at p<0.05). Depression
was significantly correlated with dissatisfaction with bowel movements, but only in the IBS-
C group.
Multiple linear regression (Table 3) was used to determine whether pain threshold, phasic
motility, tonic motility, BSI psychological scales for somatization, depression, and anxiety
and dominant stool consistency make independent contributions to IBS symptom severity
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after adjusting for the intercorrelations among these independent measures. Separate
regression models were run for overall IBS symptom severity and the component clinical
symptoms of pain intensity, pain frequency, abdominal distention severity, and
dissatisfaction with bowel movements. The regression analyses showed that a significant
amount of variance in IBS symptom severity was explained by these models for all
dependent variables except dissatisfaction with bowel movements; the amount of variance
explained (R2) ranged from 0.22 to 0.26 for the 4 significant models. Pain threshold was a
significant independent predictor (p<0.001) in all of these models except dissatisfaction with
bowel movements, and motility index during recovery was a significant predictor for pain
intensity (β=0.27, p<0.05) and abdominal distention (β =-0.29, p<0.05). Somatization was a
significant independent predictor for overall symptom severity (β =0.23, p<0.05) and
abdominal distention (β =0.24, p<0.05). For abdominal distention, having hard or lumpy
stools at least 25% of the time was also a significant predictor (β =0.20, p<0.05). Smooth
muscle tone was not a significant predictor in any of the models.
Discussion
This large, carefully conducted study yielded three important and novel findings: First, we
confirmed that visceral pain hypersensitivity is associated with (and likely contributes to)
greater severity of IBS clinical symptoms, especially the frequency and the typical intensity
of abdominal pain. This association was not explained by psychological influences on
symptom reporting. Second, when IBS patients were divided into subtypes based on the
frequency of loose or watery stools and/or the frequency of hard or lumpy stools, we found
significant differences between the subtypes in both phasic and tonic motility of the
descending colon. (Differences in phasic motility have been previously described but
differences in muscle tone have not.) Third, the relationship between clinical symptoms and
motility differed depending on predominant bowel habits. Thus, both pain thresholds and
motility have an impact on the severity of specific IBS symptoms: pain thresholds show
their strongest associations with clinical pain while motility is more strongly associated with
abdominal distention and dissatisfaction with bowel movements.
Hypersensitivity for visceral pain
Our data are consistent with a large body of research which shows that IBS patients exhibit
hypersensitivity to intra-luminal distention: 57% of our IBS patients had pain thresholds that
were below the normal range, i.e., below the confidence interval for pain thresholds in
healthy controls (Figure 2). A strength of this study is that sensory thresholds were studied
in the descending colon rather than the rectum; most previous studies of visceral perception
have tested pain sensitivity in the rectum even though it is assumed that the symptoms of
IBS originate predominantly from the colon or small intestine.
Pain thresholds were significantly correlated with the overall severity of IBS symptoms.
Individual symptoms that correlated with pain threshold were clinical pain intensity, pain
frequency, and the severity of distention. Somatization (the psychological tendency to notice
and report symptoms) was also correlated with clinical pain, abdominal distention, and
overall symptom severity. However, the association between pain threshold and clinical
symptoms remained significant after adjusting for the correlation of clinical symptoms with
somatization, anxiety, and depression (Table 3).
We observed no significant differences in pain thresholds between IBS subtypes defined by
Rome III criteria. Our findings are in agreement with previous barostat studies in the rectum
which showed no significant differences between IBS-D and IBS-C for pain thresholds15, 25,
although previous studies showed that rectal urge thresholds were lower in IBS-D patients
compared to IBS-C patients15, 25. Earlier studies using volume distentions instead of
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pressure or tension-scaled distentions, reported lower pain thresholds in IBS-D compared to
IBS-C, which is consistent with our observation that IBS-D patients have increased muscle
tone compared to IBS-C (Table 2). These data extend earlier studies by showing that in the
colon as well as the rectum, pressure-scaled pain thresholds are similar in IBS-D vs. IBS-C.
Phasic motility
Previous reports have been inconsistent as to whether IBS patients have more phasic
contractions than healthy controls under baseline conditions (i.e., fasting and without
stimulation by distention, stress, or exogenous hormones): there have been reports that IBS
patients show more baseline motility26, 27, less motility28, and about the same amount9, 10
compared to HC. We found no difference when comparing HC to all IBS patients combined.
However, the IBS-D group showed significantly more baseline contractile activity than IBS-
C. We believe our results are generalizable because our study was relatively large (n=129
IBS patients and 30 HC) and we visually identified each phasic contraction and calculated
its area under the curve rather than relying on the less precise method of allowing a
computer program to estimate the MI by integrating the area of all activity above an
arbitrary baseline.
Sustained intraluminal distention simulates a frequently occurring physiological stimulus to
the colon, namely distention of the colon by fecal material or gas. This stimulus evokes an
increase in phasic motility in both healthy controls and IBS patients, but the increase is
significantly greater in IBS patients. This exaggerated response to intraluminal distention
has been termed “hyper-reactivity” 29, and our data suggest that it is characteristic of all IBS
patients rather than being limited to one subtype. We first reported that IBS is characterized
by this exaggerated response to intraluminal distention in 198010 and other laboratories have
replicated this observation9. The response to distention is reversible – MI returns to baseline
when the distending stimulus is removed (Table 2) – and in other studies we have shown
that it is reproducible on a second occasion of testing10. These characteristics make the
response to intraluminal distention an attractive probe of motility for investigations of IBS.
However, there is overlap between IBS and HC, rendering MI of limited value as a
diagnostic marker for IBS.
Eating also stimulates an increase in the MI in both HC and IBS, as others have also
shown11. We did not find that the magnitude of the meal stimulation was significantly
greater in IBS patients as a group compared to healthy controls. There were no differences
in postprandial stimulation of MI between IBS subgroups.
To summarize our findings with respect to phasic contractions of the colon: (1) Phasic
contractions increase in reaction both to intraluminal distention and eating. (2) Compared to
healthy controls, IBS patients show an exaggerated response to intraluminal distention but a
similar response to eating. (3) IBS-D patients have more baseline phasic motility than IBS-
C, but the differences are modest and there is overlap.
Barostat bag volumes
Average barostat bag volumes measured at the IOP provide an indirect measure of smooth
muscle tone. As previously reported33, IBS patients have lower bag volumes than HC,
indicating that IBS is associated with increased smooth muscle tone. Our data confirm this
observation and extend it by showing that elevated smooth muscle tone is limited to patients
with loose or watery stools at least 25% of the time. Patients with IBS-D had significantly
lower bag volumes than patients with IBS-C (Table 2).
As previously reported27, 34, barostat bag volumes decrease substantially following a meal
(Table 2), indicating an increase in smooth muscle tone in the descending colon. However,
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the magnitude of the increase in smooth muscle tone is similar in IBS vs. HC, and it does
not distinguish patients with IBS-D from those with IBS-C. This increase in smooth muscle
tone, along with the increase in phasic motility following a meal, are believed to be part of
the physiological mechanism resulting in a tendency for flatus and defecation to occur
shortly after a meal.
We anticipated that phasic motility and smooth muscle tone would be related to IBS
symptoms, especially to dissatisfaction with bowel habits. No associations between motility
and symptoms were seen when all IBS patients were considered together. However, when
IBS subtypes defined by Rome III criteria were analyzed separately, we found significant
but contrasting associations: (a) Bowel dissatisfaction was significantly correlated with
smooth muscle tone in the IBS-D group. (b) Abdominal distention was negatively correlated
with phasic motility in IBS-C (decreased muscle contraction associated with increased
distention severity) but not IBS-D. In general, the associations between motility parameters
and clinical symptoms were weaker than the associations between pain threshold and
clinical symptoms, and some of these univariate associations could not be confirmed by
regression analysis. Other variables such as somatization are also significant predictors of
clinical symptoms in IBS.
Relationship between pain sensitivity and motility
IBS patients demonstrate both hypersensitivity and hyper-reactive motility in comparison to
healthy controls. These appear to be independent pathophysiological mechanisms because
(a) there is no correlation between them and (b) they show different relationships to the
symptoms of IBS. Pain hypersensitivity is associated with more severe clinical pain and
distention but is unrelated to dissatisfaction with bowel movements, and pain thresholds do
not differ between IBS-D and IBS-C. Phasic motility and smooth muscle tone, on the other
hand, are greater in IBS-D than they are in IBS-C and may play a role in regulating usual or
predominant bowel habits. We did not, however, find that hyper-reactive motility could
reliably differentiate between patients with IBS-D and those with IBS-C. The apparent
independence of pain hypersensitivity and motility suggests that different etiologies –
genetic, inflammatory, psychosocial, or other factors – are likely to be found for motility
hyper-reactivity and pain sensitivity, and different treatments or management strategies may
be required.
Study limitations
It is possible that the invasive nature of the test protocol, which required unsedated
sigmoidoscopy to place the motility catheter and led subjects to anticipate pain and/or
anxiety, may have biased recruitment. Consistent with this possibility, the average age of the
IBS sample was 35.8 years, which is younger than average for the IBS patients we have
studied in other settings35. Secondly, the prevalence of pain hypersensitivity may have been
underestimated since 5 IBS patients and one HC were unable or unwilling to undergo
unsedated flexible sigmoidoscopy after volunteering. Both of these study limitations could
have led to an under-representation of IBS patients with the greatest pain sensitivity, but this
would not affect the conclusions that pain sensitivity and motility reactivity are independent
pathophysiological mechanisms for IBS and that pain sensitivity is the more important
determinant of clinical symptoms. A third limitation is that the motility parameters tested
were restricted to phasic and tonic motility in the descending colon and did not include small
bowel motility36 or high amplitude propagating contractions30, 31Thus, we may have
overlooked motility patterns that show a stronger association with IBS symptom severity or
altered bowel habits.
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This study shows that both pain thresholds and motility have an impact on the severity of
specific IBS symptoms: pain thresholds show their strongest associations with clinical pain
while motility is more strongly associated with abdominal distention and dissatisfaction with
bowel movements. Our data further suggest that pain sensitivity and motility are
independent physiological mechanisms for the symptoms of IBS. The implication of these
findings for clinical practice is that treatments may have to be selected based on the patient's
predominant bowel habit in order to maximize clinical benefit. Furthermore, since most
drugs currently approved for the treatment of IBS have a greater impact on motility than on
pain, clinicians may want to supplement current drug treatments for IBS with a pain
management strategy. The implication for pharmaceutical companies is that it may be
advantageous to target pain sensitivity in future drug development programs.
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Appendix
Fig.A1 IBS symptom severity scale (IBS-SS) in subtypes of IBS and healthy
controls
IBS-SS total score for each subject was shown. Each horizontal bar indicates the median
value. HC, healthy controls (n=30); IBS-D, IBS with diarrhea (n=44); IBS-C, IBS with
constipation (n=29); IBS-M, mixed IBS (n=45). **p<0.01, vs. controls.
Fig. A2 Changes in motility index during each stimulus period in subtypes
of IBS and healthy controls
Distention, the MI during recovery and postprandial periods, is expressed as a percent of the
baseline MI for the subgroup to adjust for any baseline differences. HC, healthy controls
(light blue: n=30); IBS-D, IBS with diarrhea (n=44); IBS-C, IBS with constipation (n=29);
IBS-M, mixed IBS (n=45). Data were expressed as mean + SEM. *p<0.05 vs. controls in
same phase of testing. During distention and postprandial periods, all groups are
significantly (p<0.05) greater than baseline.
Fig. A3 Changes in Colonic Muscle Tone during each stimulus period in
subtypes of IBS and healthy controls
The colonic muscle tone was measured as mean bag volume. For the recovery and
postprandial periods, each bar shows percent of baseline value for the subgroup. HC, healthy
controls; IBS-D, IBS with diarrhea; IBS-C, IBS with constipation; IBS-M, mixed IBS. Data
were expressed as mean +/- SEM. Groups are not significantly different from each other
within conditions, but postprandial values are significantly (p<0.05) lower than baseline for
all groups.
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What is Current Knowledge
• Patients with irritable bowel syndrome (IBS) show visceral hypersensitivity or
hyper-reactive motility in the sigmoid colon and the rectum.
What is New Here
• Visceral pain sensitivity in the descending colon is associated with greater
severity of IBS clinical symptoms, especially abdominal pain.
• Phasic and tonic colon motility are related to predominant bowel habits and to
the clinical symptoms of abdominal distention and dissatisfaction with bowel
movements.
• Visceral hypersensitivity and motility are independent physiological
mechanisms for the symptoms of IBS.
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Graphs on right show sequence of pressure changes during each phase of testing. IOP
(individual operating pressure) is the pressure required to overcome the weight of overlying
tissue and minimally inflate the barostat bag.
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Fig.2. Pain threshold to intraluminal distention in the descending colon
Pain threshold in the descending colon was assessed using an electronic barostat by the
ascending method of limit (AML). Each horizontal bar indicates the median value. The pain
threshold was defined as the amount of pressure above IOP at which the subject first
reported moderate pain (absolute distending pressure minus the IOP). If the subject reached
48 mmHg without reporting moderate pain, then the pain threshold was defined as 50
mmHg minus the IOP. HC, healthy controls (n=30); IBS-D, IBS with diarrhea (n=44); IBS-
C, IBS with constipation (n=29); IBS-M, mixed IBS (n=45). *p<0.05, **p<0.01, vs.
controls.
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Fig.3. Relationship between colonic motility during distention period and pain threshold
No significant relationship was observed between colonic motility during distention period
and visceral sensitivity in IBS patients (n=129; closed circles) or healthy subjects (n=30;
open circles). Dashed lines show the 95% confidence intervals (CI): 49% of IBS patients
showed contractile activity above the CI for controls in response to intraluminal distention,
and 57% of patients had pain thresholds below the CI for controls. Of these patients, 31%
showed both visceral hyper-contractivity and pain hypersensitivity.
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